BNP-SP antibodies

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9255930
SERIAL NO

13863343

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention provides methods for predicting, diagnosing or monitoring acute cardiac disorders, cardiac transplant rejection, or distinguishing acute cardiac disorders from pulmonary disorders, by measuring BNP signal peptide levels in a sample taken from a subject shortly after onset of, or presentation with the disorder or transplant rejection.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UPSTREAM MEDICAL TECHNOLOGIES LIMITEDCHRISTCHURCH 8011

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Nicholls, Michael Gary Christchurch, NZ 9 65
Pemberton, Christopher Joseph Christchurch, NZ 18 47
Richards, Arthur Mark Christchurch, NZ 18 78
Yandle, Timothy Grant Christchurch, NZ 9 65

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 9, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00